Professor, Laboratory Medicine and Pathology, Mayo Medical School
Pathology
Dr. Daniel W. Visscher, MD
|
|
Give Review
Dr. Daniel W. Visscher practices Pathology. He researched medicine at Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care Doctor Daniel W. Visscher, MD is also a published MD. He has 62 paper published. The most recent paper is: Natural history of age-related lobular involution and impact on breast cancer risk. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases.
- Natural history of age-related lobular involution and impact on breast cancer risk.
- ERβ Expression and Breast Cancer Risk Prediction for Women with Atypias.
- Gene Expression Profiling Identifies Responsive Patients with Cancer of Unknown Primary Treated with Carboplatin, Paclitaxel, and Everolimus: NCCTG N0871 (Alliance).
- Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
- Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.
- Model for individualized prediction of breast cancer risk after a benign breast biopsy.
- Flat epithelial atypia and risk of breast cancer: A Mayo cohort study.
- Circulating sex hormones and terminal duct lobular unit involution of the normal breast.
- Pregnancy-associated plasma protein-A expression in human breast cancer.
- Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology.
- Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer.
- Immune cell quantitation in normal breast tissue lobules with and without lobulitis.
- Regional differences in breast cancer biomarkers in american Indian and alaska native women.
- Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study.
- Sclerosing adenosis and risk of breast cancer.
- Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple negative breast cancer.
- Management of Benign Intraductal Solitary Papilloma Diagnosed on Core Needle Biopsy.
- Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women.
- Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
- Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.
- Lobular neoplasia: how to manage with partial understanding.
- p16INK4a expression and breast cancer risk in women with atypical hyperplasia.
- Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues.
- Tissue composition of mammographically dense and non-dense breast tissue.
- Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer.
- Pseudoangiomatous stromal hyperplasia and breast cancer risk.
- Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer.
- Independent association of lobular involution and mammographic breast density with breast cancer risk.
- HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial.
- Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response.
- Association between mammographic density and age-related lobular involution of the breast.
- Novel breast tissue feature strongly associated with risk of breast cancer.
- New frontiers in pathology.
- Update on selected salivary gland neoplasms.
- Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
- Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.
- Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
- What values are critical?
- Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer.
- Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
- Age-related lobular involution and risk of breast cancer.
- An analysis of breast cancer risk in women with single, multiple, and atypical papilloma.
- Histologic spectrum of idiopathic interstitial pneumonias.
- Bronchiolitis: the pathologist's perspective.
- Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.
- Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastat...
- Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
- Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining.
- Benign breast disease and the risk of breast cancer.
- Influence of lactation history on breast nipple aspirate fluid yields and fluid composition.
- Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas.
- Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
- Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma.
- Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome.
- Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stro...
- Clinicopathologic analysis of breast lesions associated with multiple papillomas.
- Rad6 overexpression induces multinucleation, centrosome amplification, abnormal mitosis, aneuploidy, and transformation.
- Clinicopathologic Analysis of Fas, Fas Ligand, and Other Biomarkers in Locally Advanced Breast Carcinoma.
- The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer.
- Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance.
Schools
Indiana University School Of Medicine
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Alabama Medical Center -
Indiana University School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871566174 |
| Last Name Of The Provider | VISSCHER |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Mariam P. Alexander, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad M. Botz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cecilia Wu, MD
This Doctor is OpenDoctor Recommended.
|